Sempermed USA, Inc. Awarded Contract to Manufacture NOVAPLUS Exam Gloves
Sempermed USA, Inc., a leading manufacturer and supplier of hand protection, announces it has been awarded an agreement as the sole source manufacturer for Novations NOVAPLUS® Exam Glove line.
Novation, one of the healthcare industry's leading supply contracting companies, stated that Sempermed was rated among the highest for acceptability by their Clinical and Supply Council and that was a key factor in the selection process.
Beginning Jan. Â 1, 2011, the NOVAPLUS contract with Sempermed will offer the members of VHA, University HealthSystem Consortium (UHC) and Provista a complete line of quality nitrile, vinyl and latex examination gloves.
NOVAPLUS, Novations private label brand of pharmacy and medical-surgical products, delivers the best financial value for VHA, UHC and Provista members on the most frequently-purchased commodity products. Originally founded in 1985 as VHAPLUS, the private label currently includes more than 1,100 products with annual purchases of $1.6 billion.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
